These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 28598086)

  • 1. [High Mobility Group Chromosomal Protein N2 Inhibit Cervical Cancer Transplanted in Nude Mice].
    Luo B; Zhang QW; Xu Y; Meng J; Wang XL; Li L; He YD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 47(5):718-721. PubMed ID: 28598086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitory effects of high mobility group chromosomal protein N2 on human tongue carcinoma transplanted in nude mice].
    Liu X; Dong X; Zhang Y; Zhang P; Li X; Chen S; Feng Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2014 Feb; 32(1):5-8. PubMed ID: 24665631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of high-intensity focused ultrasound in combination with cisplatin using a Xenograft model of cervical cancer.
    Lee YY; Cho YJ; Choi JJ; Choi CH; Kim TJ; Kim BG; Bae DS; Kim YS; Lee JW
    Anticancer Res; 2012 Dec; 32(12):5285-9. PubMed ID: 23225428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGN2 protein inhibits the growth of infected T24 cells in vitro.
    Wei D; Zhang P; Zhou M; Feng Y; Chen Q
    J Cancer Res Ther; 2014; 10(2):299-304. PubMed ID: 25022381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of IL-24 and cisplatin inhibits angiogenesis and lymphangiogenesis of cervical cancer xenografts in a nude mouse model by inhibiting VEGF, VEGF-C and PDGF-B.
    Wang Z; Lv J; Zhang T
    Oncol Rep; 2015 May; 33(5):2468-76. PubMed ID: 25778843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleosome-binding protein HMGN2 exhibits antitumor activity in human SaO2 and U2-OS osteosarcoma cell lines.
    Liang G; Xu E; Yang C; Zhang C; Sheng X; Zhou X
    Oncol Rep; 2015 Mar; 33(3):1300-6. PubMed ID: 25530340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
    Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
    Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel.
    Murakami T; Murata T; Kawaguchi K; Kiyuna T; Igarashi K; Hwang HK; Hiroshima Y; Hozumi C; Komatsu S; Kikuchi T; Lwin TM; Delong JC; Miyake K; Zhang Y; Tanaka K; Bouvet M; Endo I; Hoffman RM
    Anticancer Res; 2017 Jan; 37(1):61-65. PubMed ID: 28011474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of HMGN2 on proliferation and apoptosis of MCF-7 breast cancer cells.
    Fan B; Shi S; Shen X; Yang X; Liu N; Wu G; Guo X; Huang N
    Oncol Lett; 2019 Jan; 17(1):1160-1166. PubMed ID: 30655878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory effect of emodin on the growth of cervical cancer in tumor-transplanted mice and underlying mechanism].
    Zhang J; Hu Z; Chen Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):350-4. PubMed ID: 25744842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model.
    Straughn JM; Oliver PG; Zhou T; Wang W; Alvarez RD; Grizzle WE; Buchsbaum DJ
    Gynecol Oncol; 2006 Apr; 101(1):46-54. PubMed ID: 16271751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Role of HMGN2 in the Development of Periodontitis Dental Plaque].
    Luo Y; Li Q; Fan YP; Chen J; Zhang P; Feng Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Jul; 47(4):491-494. PubMed ID: 28591948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of IL-24 and cisplatin inhibits cervical cancer growth in a xenograft nude mice model.
    Li L; Wang ZX; Wang ZH
    Asian Pac J Cancer Prev; 2011; 12(12):3293-8. PubMed ID: 22471469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapeutic effect and molecular mechanisms of metformin and cisplatin in human lung cancer xenografts in nude mice.
    Chen YQ; Chen G
    J Cancer Res Ther; 2015; 11(2):324-30. PubMed ID: 26148594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of a protein kinase C inhibitor combined with cisplatin on non-small cell lung cancer].
    Gao ZQ; Han BH; Sha HF; Shi ZY; Yang XH; Feng JX
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Apr; 33(4):284-8. PubMed ID: 20646461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of bevacizumab and cisplatin on human lung adenocarcinoma A549/DDP xenografts in nude mice].
    Dai M; Luo RC; Zheng DY; Lü CW; Ding XM
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1402-5. PubMed ID: 17884788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-mobility group protein N2 (HMGN2) inhibited the internalization of Klebsiella pneumoniae into cultured bladder epithelial cells.
    Wu G; Cao Y; Fan B; Zheng F; Gao X; Liu N; Liu X; Huang N
    Acta Biochim Biophys Sin (Shanghai); 2011 Sep; 43(9):680-7. PubMed ID: 21778192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
    Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
    Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adenovirus-delivered tissue inhibitor of metalloproteinases-3 transfection increases the sensitivity of cervical cancer cells to cisplatin].
    Zhang Y; Lin C; Qian HL; Lang JH; Fu M; Zhang XY; Liang X; Duan H; Xiang Y
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):25-9. PubMed ID: 17575689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of HMGN2-tag constructs to analysis of HMGN2 distribution in HeLa cells].
    Xiong W; Feng Y; Huang N; Wu Q; Li X; Wang B
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Oct; 22(5):1015-9. PubMed ID: 16294743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.